Lara Case

START NOW
PURCHASE

Course Overview

This advanced, clinically focused course provides practitioners with a real-world demonstration of the application of botulinum toxin to multiple sites. Designed for injectors looking to refine their clinical judgment, this course follows expert faculty as they evaluate and treat actual patients requiring multi-site botulinum toxin interventions across complex facial zones.

Participants will observe the full clinical workflow in real time: from the initial aesthetic consultation and dynamic muscle mapping to the precise selection of injection points and dosing adjustments. By analyzing diverse patient anatomies and variable muscle strengths, clinicians will learn how to safely manage drug diffusion, avoid adverse outcomes, and coordinate multi-zone injections for balanced, natural, and highly customized patient results.

Learning Objectives

 1.  Analyze the patient's unique presentation to design a highly customized, target-specific treatment plan.
  2.  Adapt dosing strategies based on the patient's individual facial asymmetry and structural anatomy.
  3.  Evaluate the specific injection techniques and needle placement strategies used to optimize results and minimize product diffusion for this patient.
  4.  Formulate proactive clinical decisions based on this case scenario to consistently avoid adverse events in similar patient profiles.

References

Ahsanuddin S, Roy S, Nasser W, Povolotskiy R, Paskhover B.Adverse events associated with Botox as reported in a Food and Drug Administration database. Aesthetic Plast Surg. 2021;45(3):1201-1209.

Alam M, Bolotin D, Carruthers J, et al.Consensus statement regarding storage and reuse of previously reconstituted neuromodulators. Dermatol Surg. 2015;41(3):321-326.

Cohn JE, Greco TM.Advanced techniques for the use of neurotoxins in non-surgical facial rejuvenation. Aesthetic plastic surgery. 2020 Oct;44(5):1788-99.

Jabbour S, Kechichian E, Awaida C, Nasr M.Updates in the treatment of the lower face and neck with botulinum toxin injections. Aesthetic Surg J. 2019 Mar 14;39(4):NP93-4.

Park MY, Ahn KY.Scientific review of the aesthetic uses of botulinum toxin type A. Arch Craniofac Surg. 2021;22(1):1-10. 

Sethi N, Singh S, DeBoulle K, Rahman E.A review of complications due to the use of botulinum toxin A for cosmetic indications. Aesthetic Plast Surg. 2021;45(3):1210-1220.

Small R. Small’s Practical Guide to Botulinum Toxin Procedures. Lippencott, Williams & Wilkins. Philadelphia, PA. 2024.

Disclosures

The planners, faculty, and peer-reviewers of the CE activity have no relevant financial relationships with ineligible companies to disclose.

Planners

Jade Ryan, MA, Ed
Meghan Craddock, RN
Jaime Shaffer

Peer Reviewer

Stanislava Matejin, MD Family Medicine Resident at Dominican Hospital.

Speaker

Rebecca Small, MD

Speaker Bio

Rebecca Small, MD is a leading authority in combining non-surgical medical aesthetic therapies to slow the signs of aging. She is a graduate of Cambridge University, England, and Harvard Medical School. Dr. Small is a Clinical Professor at the University of California San Francisco (UCSF) School of Medicine where she trains Plastic Surgery and Family Medicine physicians on non-surgical medical aesthetics.

Dr. Small is also the best-selling author of the Practical Guide to medical aesthetics textbook series. The series, which covers botulinum toxins, dermal fillers, lasers, and medical skincare, has been translated into 8 languages and sold more than 50,000 copies worldwide. These textbooks consistently achieve “#1 Best Seller” in Amazon’s Plastic Surgery, Dermatology, and Laser Medicine categories; garnering more than 1,000 5-star reviews.

At RSMD Medical Aesthetics, Dr. Small serves as the hands-on Medical Director. 

A woman with shoulder-length brown hair wearing a white coat with black edges and a name tag is standing in front of a bookshelf with medical books about aesthetic procedures. There are two potted plants on the shelves and a partial view of a computer monitor.

Instructions to Obtain Credit

For each module:

  1. Launch the activity

  2. View the case online

  3. Read the assigned reading

  4. Complete the RSMD Workbook for Upper Face

  5. Complete the post-tests and obtain a passing score of 80%

  6. Complete the program evaluation

Joint Accreditation Statement:

Provided by UAMS after approval.

Credit Designation Statements:

Provided by UAMS after approval.

Joint Accreditation Statement

Jointly Accredited Program

In support of improving patient care, University of Arkansas for Medical Sciences and RSMD Aesthetics Training are jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Release and expiration: 4/24/26 to 4/24/29.

Credit Designation Statements

AMA Credit Designation Statement

The University of Arkansas for Medical Sciences designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation Statement

The University of Arkansas for Medical Sciences designates this live activity for a maximum of 1.5 ANCC contact hours.  Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.

A woman in a hospital bed smiling at three nurses or medical staff members in a healthcare setting. The room has large windows with blinds and medical equipment in the background.

AAPA Credit Designation Statement

The University of Arkansas for Medical Sciences has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Policy Statement

It is the policy of the University of Arkansas for Medical Sciences (UAMS), Office of Continuing Education (OCE) to ensure balance, independence, objectivity, and scientific rigor in all directly or jointly provided educational activities. All individuals who are in a position to control the content of the educational activity (course/activity directors, planning committee members, staff, teachers, or authors of CE) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship. The ACCME describes relevant financialrelationships as those in any amount occurring within the past 24 months that create a conflict of interest. Individuals who refuse to disclose will be disqualified from participation in the development, management, presentation, or evaluation of the CE activity.